Skip to content

Validation of a remote testing hearing diagnostic audiometer for a hospital

earKART OMNI A remote audiometry testing device Validation of a remote testing hearing diagnostic audiometer for hospital and community settings - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101784
Enrollment
60
Registered
2026-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H908- Mixed conductive and sensorineuralhearing loss, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: earKART OMNI (A remote audiometry testing device): earKART OMNI is a remote audiometry testing device that enables the audiologist to perform audiometry test for

Sponsors

The Indian Council of Medical Research (ICMR), New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adults (more than 18 years) attending the outpatient department (OPD) of ENT Department 2. Individuals giving consent for participation.

Exclusion criteria

Exclusion criteria: 1. Individuals with active discharge will not be included for tympanometry and OAE testing. 2. Individuals not giving consent for participation.

Design outcomes

Primary

MeasureTime frame
The expected outcome is a comprehensive validation of the earKART OMNI remote hearing testing device in both hospital setting. Deliverables will include a detailed report on the device s diagnostic accuracy and user-friendliness supported by analytical validation data. Findings will provide essential evidence for potential public health deployment of earKART OMNI device in hearing loss diagnosis.Timepoint: The outcomes of both the devices will be evaluated at the end of data collection.

Secondary

MeasureTime frame
The Secondary outcome of the study will be comparative values of sensitivity, specificity, positive predictive & negative predictive values using both the devices in subjects variable degree of Hearing Loss.Timepoint: All the analysis will be perform at the end of data collection.

Countries

India

Contacts

Public ContactDr Kapil Sikka

All India Institute of Medica Sciences, New Delhi

kapil_sikka@yahoo.com01126594922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026